MSV
HZNP

MN Services Vermogensbeheer’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MN Services Vermogensbeheer’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-106,300
Closed -$12.3M – 444
2023
Q3 		$12.3M Buy
106,300
+3,000
+3% +$322K 0.12% 208
2023
Q2 		$10.6M Sell
103,300
-2,900
-3% -$306K 0.1% 242
2023
Q1 		$11.6M Buy
106,200
+3,300
+3% +$365K 0.12% 216
2022
Q4 		$11.7M Sell
102,900
-16,800
-14% -$1.4M 0.13% 209
2022
Q3 		$7.41M Sell
119,700
-7,000
-6% -$489K 0.08% 287
2022
Q2 		$10.1M Sell
126,700
-26,800
-17% -$2.54M 0.09% 254
2022
Q1 		$16.1M Sell
153,500
-11,000
-7% -$1.07M 0.11% 209
2021
Q4 		$17.7M Buy
164,500
+6,800
+4% +$742K 0.1% 224
2021
Q3 		$17.3M Buy
157,700
+1,600
+1% +$166K 0.11% 229
2021
Q2 		$12.3M Buy
+156,100
New +$14.4M 0.1% 242

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MN Services Vermogensbeheer's HZNP Position: Q4 2023 in Review

MN Services Vermogensbeheer sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 106,300 shares — an estimated $12.3M sold.

MN Services Vermogensbeheer first reported a position in HZNP in Q2 2021 and held it in 10 quarters. The position peaked at $17.7M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • MN Services Vermogensbeheer reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • MN Services Vermogensbeheer sold 106,300 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $12.3M.
  • MN Services Vermogensbeheer first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 10 quarters.
  • MN Services Vermogensbeheer's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $17.7M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on MN Services Vermogensbeheer's 13F filing for Q4 2023, filed 29 Jan 2024.